Molina Healthcare/$MOH
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Molina Healthcare
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.
- Ticker
- $MOH
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 19,000
- Headquarters
- Long Beach, United States
- Website
- www.molinahealthcare.com
MOH Metrics
BasicAdvanced
$11B
-
-$0.94
0.78
-
Price and volume
Market cap
$11B
Beta
0.78
52-week high
$244.89
52-week low
$121.06
Average daily volume
931K
Financial strength
Current ratio
1.692
Quick ratio
1.615
Long term debt to equity
0.951
Total debt to equity
0.951
Interest coverage (TTM)
1.26%
Profitability
EBITDA (TTM)
352
Gross margin (TTM)
8.35%
Net profit margin (TTM)
-0.11%
Operating margin (TTM)
0.64%
Effective tax rate (TTM)
-17.07%
Revenue per employee (TTM)
$2,210,000
Management effectiveness
Return on assets (TTM)
1.07%
Return on equity (TTM)
-1.15%
Valuation
Price to revenue (TTM)
0.263
Price to book
2.71
Price to tangible book (TTM)
5.41
Price to free cash flow (TTM)
46.491
Free cash flow yield (TTM)
2.15%
Free cash flow per share (TTM)
4.66
Growth
Revenue change (TTM)
-1.78%
Earnings per share change (TTM)
-105.79%
3-year revenue growth (CAGR)
8.99%
10-year revenue growth (CAGR)
9.70%
3-year earnings per share growth (CAGR)
-61.13%
10-year earnings per share growth (CAGR)
-8.51%
What the Analysts think about MOH
Analyst ratings (Buy, Hold, Sell) for Molina Healthcare stock.
Analyst projections of the future price of Molina Healthcare stock.
Bulls say / Bears say
Medicaid margins may be near a trough: Molina expects 2027 rate increases of about 6%, roughly in line with its 5.5%–6% medical cost trend forecast. If those rates hold, they could stabilise margins and leave room for recovery. (Healthcare Dive)
Molina expects to harvest about $4 per share of earnings from existing initiatives in 2027, including the Florida contract reaching break-even, the end of losses from its traditional Medicare Advantage product and operating leverage. This offers a route to profit growth without relying on a recovery in existing Medicaid margins. (The Motley Fool)
Molina secured an Illinois Medicaid contract expected to begin in 2027 and run for four and a half years, with options for extensions. The award supports longer-term revenue visibility in a core business line. (Molina Healthcare Inc.)
Profitability is under pressure: third-quarter adjusted earnings per share fell 53% year on year, while the medical care ratio rose to 92.9% from 92.6%. For 2026, the company expects Medicaid cost trend of 5.5%, above its 4.5% rate increase outlook. (Molina Healthcare Inc., Healthcare Dive)
Membership is contracting: Molina's total membership fell 14% year on year to 4.9 million by September, mainly because of Medicaid market contraction and its smaller Marketplace business. It also expects to lose about 6% of Medicaid members in 2027 as work requirements and eligibility checks take effect. (Molina Healthcare Inc., Healthcare Dive)
Court challenges have delayed Molina's planned Georgia and Texas Medicaid contract launches to late 2027 or 2028, pushing about $1.3 billion of premium revenue beyond the earlier timetable. Management also reduced its 2027 premium outlook from $46.5 billion to at least $45 billion. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2026.
MOH Financial Performance
Revenues and expenses
MOH Earnings Performance
Company profitability
Upcoming events
No upcoming events
MOH News
AllArticlesVideos
Funds containing MOH
AllUSDEURGBP
Fund name | Fund size | $MOH weighting |
|---|---|---|
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.51% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.4B | 0.34% |
SPDR S&P 400 US Mid Cap£SPX4 | $6.4B | 0.34% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $3.2B | 0.17% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $3.2B | 0.17% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.